Focus on Paediatric IBD and Therapeutic Drug Monitoring (TDM)
Inflammatory Bowel Disease (IBD) remains an incurable condition, posing significant challenges for both patients and healthcare providers. Achieving and maintaining remission is the primary objective, as flare-ups can worsen over time. For paediatric patients, these challenges are further compounded by their developing bodies and the long-term implications of their treatment plans.